Neurocrine Biosciences
NBIX
Reported
Monday, February 6
Q4 2022 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | 1.14 | 1.24 | 0.10 | 8.77% |
| Revenue | 409M | 412M | 2.91M | 0.71% |
WhatIF - Earnings
EPS Beat Expectations by $0.10
Neurocrine Biosciences (NBIX:NASDAQ) has never beaten EPS by this much before
There’s a first time for everything